Samsung Bioepis, Republic of Korea
Vice President, Commercial Strategy Team Leader
.Albert Kim is Vice President and Commercial Strategy Team Leader at Samsung Bioepis, overseeing commercialization of biosimilar products under partnership with Organon. He joined Samsung Bioepis in September 2020 as Vice President and Commercial Strategy Team Leader to head its commercial operations, which covers the global oncology business and immunology businesses outside Europe.
Throughout his 20-year global pharmaceutical career, Albert Kim has held leadership roles across commercial, operation, and finance sectors in Asia-Pacific including South Korea, as well as in Europe, the Middle East and North Africa.